Presentation is loading. Please wait.

Presentation is loading. Please wait.

GR CAFs modulate the EGFR-TKI response in cocultured tumor cells.

Published byPertti Aaltonen Modified over 4 years ago

Similar presentations

Presentation on theme: "GR CAFs modulate the EGFR-TKI response in cocultured tumor cells."— Presentation transcript:

1 GR CAFs modulate the EGFR-TKI response in cocultured tumor cells.
GR CAFs modulate the EGFR-TKI response in cocultured tumor cells. A and B, immunoblots for pEGFR, pMAPK, and pAkt in GP epithelial tumor cells (A) and HCC827 cells (B) showing the effect of gefitinib treatment upon coculture with GP or GR CAFs. Densitometric intensities for each marker were determined, and the marker that shows the most dramatic modification in each cell type in presence of gefitinib is presented. Sheldon R. Mink et al. Mol Cancer Res 2010;8: ©2010 by American Association for Cancer Research

Download ppt "GR CAFs modulate the EGFR-TKI response in cocultured tumor cells."

Similar presentations

GM-CSF induces tumor cell EMT and stemness.

GM-CSF induces tumor cell EMT and stemness.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Cetuximab treatment increases IFNγ receptor 1 expression.

Cetuximab treatment increases IFNγ receptor 1 expression.
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.

The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.
Leto et al., Supplementary Figure S3

Leto et al., Supplementary Figure S3
NICD1 immunohistochemical staining in normal and tumor tissue.

NICD1 immunohistochemical staining in normal and tumor tissue.
Immunoblotting samples (A and F) and densitometric analysis of ASC1 (B and G), NLRP3 (C and H), TNFα (D and I) and Caspase-1 (E and J) expression in the.

Immunoblotting samples (A and F) and densitometric analysis of ASC1 (B and G), NLRP3 (C and H), TNFα (D and I) and Caspase-1 (E and J) expression in the.
BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.

BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.
eNOS regulated IR-induced NO generation and EGFR signal activation.

eNOS regulated IR-induced NO generation and EGFR signal activation.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.

A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
GA blocks HIF activity and reduces HIF target expression.

GA blocks HIF activity and reduces HIF target expression.
PTB-independent ShcA pools require Src to promote mammary tumorigenesis. PTB-independent ShcA pools require Src to promote mammary tumorigenesis. A, Src.

PTB-independent ShcA pools require Src to promote mammary tumorigenesis. PTB-independent ShcA pools require Src to promote mammary tumorigenesis. A, Src.
Coinjection of CAFs induces a collagen cross-link switch in tumor stroma. Coinjection of CAFs induces a collagen cross-link switch in tumor stroma. A,

Coinjection of CAFs induces a collagen cross-link switch in tumor stroma. Coinjection of CAFs induces a collagen cross-link switch in tumor stroma. A,
Interaction of aggregates with CAF network structures.

Interaction of aggregates with CAF network structures.
Peripheral CAF model. Peripheral CAF model. A, bright field (top) and fluorescence (bottom) micrographs of aggregates that contain RFP-tagged 344SQ cells.

Peripheral CAF model. Peripheral CAF model. A, bright field (top) and fluorescence (bottom) micrographs of aggregates that contain RFP-tagged 344SQ cells.
A, cytotoxicity induced on HER2 3+ USC (ARK-2), HER2 0/1+ USC (ARK-4), and ARK-2/ARK-4 cocultures with 1 μg/mL of SYD985, T-DM1, and ADC isotype control.

A, cytotoxicity induced on HER2 3+ USC (ARK-2), HER2 0/1+ USC (ARK-4), and ARK-2/ARK-4 cocultures with 1 μg/mL of SYD985, T-DM1, and ADC isotype control.
Expression profile of RSPO1 and 2 in gastric cancer.

Expression profile of RSPO1 and 2 in gastric cancer.
In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.

In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.
BME treatment increases granzyme B expression in NK 3.3 cells.

BME treatment increases granzyme B expression in NK 3.3 cells.
In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.

In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.

Similar presentations

Ads by Google